Actively Recruiting

Phase 3
Age: 1Day - 104Weeks
All Genders
NCT04177914

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Led by University of Utah · Updated on 2025-06-11

176

Participants Needed

21

Research Sites

371 weeks

Total Duration

On this page

Sponsors

U

University of Utah

Lead Sponsor

U

University of Alabama at Birmingham

Collaborating Sponsor

AI-Summary

What this Trial Is About

Hydrocephalus is a potentially debilitating neurological condition that primarily affects babies under a year of age and has traditionally been treated by inserting a shunt between the brain and the abdomen. A newer endoscopic procedure offers hope of shunt- free treatment that may reduce complications over a child's life, but it is not clear if the endoscopic procedure results in similar intellectual outcome as shunt. Therefore, the investigators propose a randomized trial to compare intellectual outcome and brain structural integrity between these two treatments, to help families make the best treatment decision for their baby.

CONDITIONS

Official Title

HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Who Can Participate

Age: 1Day - 104Weeks
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Corrected age less than 104 weeks (about 2 years)
  • Child is at least 37 weeks post menstrual age
  • Child has symptomatic hydrocephalus defined by ventriculomegaly on MRI and at least one related symptom like large head size, bulging fontanelle, eye movement issues, CSF leak, papilledema, tense fluid collections, vomiting, irritability, bradycardia, apnea, or elevated intracranial pressure
  • No prior shunt insertion or endoscopic third ventriculostomy (ETV) procedure (temporary devices or external drains allowed)
Not Eligible

You will not qualify if you...

  • Hydrocephalus caused by intraventricular hemorrhage in a child born before 37 weeks gestation
  • Brain anatomy unsuitable for ETV+CPC or anterior shunt placement due to moderate to severe adhesions, closed foramina of Monro, thick or narrow third ventricle, or lesions preventing shunt placement
  • Underlying condition with high risk of death within 12 months
  • Hydrocephalus with loculated cerebrospinal fluid compartments
  • Peritoneal cavity unsuitable for shunt placement
  • Active cerebrospinal fluid infection
  • Hydranencephaly
  • Need for additional intraventricular procedures beyond the first permanent treatment for hydrocephalus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

Children's of Alabama

Birmingham, Alabama, United States, 35233

Actively Recruiting

2

Phoenix Children's Hospital

Phoenix, Arizona, United States, 85016

Not Yet Recruiting

3

Children's Hospital of Los Angeles

Los Angeles, California, United States, 90027

Actively Recruiting

4

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

5

Yale University

New Haven, Connecticut, United States, 06520

Active, Not Recruiting

6

Wolfson Children's Hospital

Jacksonville, Florida, United States, 32207

Actively Recruiting

7

Arnold Palmer Hospital for Children

Orlando, Florida, United States, 32806

Actively Recruiting

8

Trustees of Indiana University

Indianapolis, Indiana, United States, 46202

Not Yet Recruiting

9

Johns Hopkins Children's Center

Baltimore, Maryland, United States, 21287

Actively Recruiting

10

St. Louis Children's Hospital

St Louis, Missouri, United States, 63110

Actively Recruiting

11

Nationwide Children's Hospital

Columbus, Ohio, United States, 43205

Actively Recruiting

12

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, United States, 15224

Actively Recruiting

13

The Pennsylvania State University

University Park, Pennsylvania, United States, 16802

Active, Not Recruiting

14

Monroe Carell Jr. Children's Hospital at Vanderbilt

Nashville, Tennessee, United States, 37232

Actively Recruiting

15

Texas Children's Hospital

Houston, Texas, United States, 77030

Actively Recruiting

16

Primary Children's Hospital

Salt Lake City, Utah, United States, 84118

Actively Recruiting

17

Virginia Commonwealth University

Richmond, Virginia, United States, 23284

Active, Not Recruiting

18

Seattle Children's Hospital

Seattle, Washington, United States, 98105

Actively Recruiting

19

Alberta Children's Hospital

Calgary, Alberta, Canada, T3B 6A8

Actively Recruiting

20

British Columbia Children's Hospital

Vancouver, British Columbia, Canada, V6H 3V4

Actively Recruiting

21

The Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8

Actively Recruiting

Loading map...

Research Team

N

Nichol Nunn

CONTACT

J

Jason Clawson

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here